Back
MFS Multimarket Income Trust Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Buy
53
MMT
MFS Multimarket Income Trust
Last Price:
$4.73
Seasonality Move:
2.36%
Buy
75
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$111.84
Seasonality Move:
-9.01%
Buy
53
MFS Multimarket Income Trust (MMT)
is a Buy
Is MFS Multimarket Income Trust a Buy, Sell or Hold?
-
The current MFS Multimarket Income Trust [MMT] share price is $4.70. The Score for MMT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
MMT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $117.62. The Score for RYTM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MMT Stock Price Chart
What is MFS Multimarket Income Trust's stock price today?
-
The MFS Multimarket Income Trust share price today is $4.70The current trend is relatively stagnant and MMT is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $117.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight buying pressure.
MMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 50.56 | Buy |
| Chaikin Money Flow: | -104197 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.66 - 4.72) | Buy |
| Bollinger Bands (100): | (4.67 - 4.77) | Sell |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.17 | Buy |
| Relative Strength Index (14 RSI): | 65.29 | Buy |
| Chaikin Money Flow: | 622990 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.54 - 107.68) | Buy |
| Bollinger Bands (100): | (93.66 - 107.58) | Buy |
MMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.71 | Sell |
| 20-day SMA: | 4.68 | Buy |
| 50-day SMA: | 4.71 | Sell |
| 200-day SMA: | 4.66 | Buy |
| 8-day EMA: | 4.7 | Sell |
| 20-day EMA: | 4.7 | Buy |
| 50-day EMA: | 4.71 | Sell |
| 200-day EMA: | 4.69 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.58 | Buy |
| 20-day SMA: | 104.18 | Buy |
| 50-day SMA: | 104.81 | Buy |
| 200-day SMA: | 81.44 | Buy |
| 8-day EMA: | 107.12 | Buy |
| 20-day EMA: | 105.38 | Buy |
| 50-day EMA: | 103.54 | Buy |
| 200-day EMA: | 86.38 | Buy |
MFS Multimarket Income Trust Earnings Growth & MMT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.
MFS Multimarket Income Trust Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||